These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 17587744)

  • 1. Upstream therapy for atrial fibrillation.
    Kumagai K
    Circ J; 2007; 71 Suppl A():A75-81. PubMed ID: 17587744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation and renin-angiotensin system.
    Serra JL; Bendersky M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):215-23. PubMed ID: 19124423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and statins: no effect on ablation outcome after ablation of atrial fibrillation.
    Richter B; Derntl M; Marx M; Lercher P; Gössinger HD
    Am Heart J; 2007 Jan; 153(1):113-9. PubMed ID: 17174648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant therapy for atrial fibrillation.
    Mohammed KS; Kowey PR; Musco S
    Future Cardiol; 2010 Jan; 6(1):67-81. PubMed ID: 20014988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of renin angiotensin system blockade in the treatment of atrial fibrillation.
    Dilaveris P; Giannopoulos G; Synetos A; Stefanadis C
    Curr Drug Targets Cardiovasc Haematol Disord; 2005 Oct; 5(5):387-403. PubMed ID: 16248831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation: Blockade of the renin-angiotensin system in atrial fibrillation.
    Kuzniatsova N; Shantsila E; Lip GY
    Nat Rev Cardiol; 2010 Aug; 7(8):428-30. PubMed ID: 20657612
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of renin-angiotensin system inhibitors in atrial fibrillation.
    Disertori M; Latini R; Maggioni AP
    J Cardiovasc Med (Hagerstown); 2011 May; 12(5):374; author reply 375. PubMed ID: 21451337
    [No Abstract]   [Full Text] [Related]  

  • 8. Focus on renin-angiotensin system modulation and atrial fibrillation control after GISSI AF results.
    Durin O; Pedrinazzi C; Inama G
    J Cardiovasc Med (Hagerstown); 2010 Dec; 11(12):912-8. PubMed ID: 20729747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upstream therapies for management of atrial fibrillation: review of clinical evidence and implications for European Society of Cardiology guidelines. Part I: primary prevention.
    Savelieva I; Kakouros N; Kourliouros A; Camm AJ
    Europace; 2011 Mar; 13(3):308-28. PubMed ID: 21345926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Upstream therapy of atrial fibrillation in patients with heart failure].
    Alboni P; Gianfranchi L; Pacchioni F
    G Ital Cardiol (Rome); 2009 Sep; 10(9):566-71. PubMed ID: 19891248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug therapy for atrial fibrillation.
    Conway EL; Musco S; Kowey PR
    Cardiol Clin; 2009 Feb; 27(1):109-23, ix. PubMed ID: 19111768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers decrease the incidence of atrial fibrillation: a meta-analysis.
    Huang G; Xu JB; Liu JX; He Y; Nie XL; Li Q; Hu YM; Zhao SQ; Wang M; Zhang WY; Liu XR; Wu T; Arkin A; Zhang TJ
    Eur J Clin Invest; 2011 Jul; 41(7):719-33. PubMed ID: 21250983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications.
    Lau YF; Yiu KH; Siu CW; Tse HF
    J Hum Hypertens; 2012 Oct; 26(10):563-9. PubMed ID: 22129612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of atrial fibrillation].
    Kirchhof P; Breithardt G
    Internist (Berl); 2007 Aug; 48(8):819-29; quiz 830-1. PubMed ID: 17632695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upstream therapy for atrial fibrillation in heart failure.
    Goette A
    Heart Fail Clin; 2013 Oct; 9(4):417-25, viii. PubMed ID: 24054475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-arrhythmic drug therapy for atrial fibrillation: current anti-arrhythmic drugs, investigational agents, and innovative approaches.
    Savelieva I; Camm J
    Europace; 2008 Jun; 10(6):647-65. PubMed ID: 18515286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial structural remodeling as an antiarrhythmic target.
    Burstein B; Nattel S
    J Cardiovasc Pharmacol; 2008 Jul; 52(1):4-10. PubMed ID: 18594481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Atrial fibrillation and renin-angiotensin system].
    Yamashita T
    Nihon Rinsho; 2007 Mar; 65(3):569-74. PubMed ID: 17354577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upstream effect for atrial fibrillation: still a dilemma?
    Calò L; Martino A; Sciarra L; Ciccaglioni A; De Ruvo E; De Luca L; Sette A; Giunta G; Lioy E; Fedele F
    Pacing Clin Electrophysiol; 2011 Jan; 34(1):111-28. PubMed ID: 21029134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.